Navigation Links
PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S.
Date:11/26/2008

>

About PLC Systems Inc.

PLC Systems Inc. is a medical technology company specializing in innovative technologies for the cardiac and vascular markets.

PLC's newest product, RenalGuard, is approved for sale in the EU as a general fluid balancing device. The RenalGuard System consists of a unique, proprietary, closed loop, software-controlled console and accompanying single-use sets that can be used by physicians and nurses to balance patient fluid levels during a variety of medical procedures. With its automated matched fluid replacement capability, RenalGuard is intended to minimize the risk to patients of over- or under-hydration while also largely eliminating what can be an intensive and time consuming manual fluid balancing task for physicians and nurses.

Headquartered in Franklin, Massachusetts, PLC pioneered the CO2 Heart Laser System, which cardiac surgeons use to perform CO2 transmyocardial revascularization (TMR) to alleviate symptoms of severe angina. CO2 TMR offers a treatment option for angina patients who suffer from severe coronary artery disease. The C02 Heart Laser is the world's first TMR angina relief device cleared for commercial distribution by both the U.S. Food and Drug Administration and Japanese Ministry of Health, Labor and Welfare, and to obtain a CE Mark for distribution within the EU.

Additional company information can be found at www.plcmed.com.

This press release contains "forward-looking" statements. For this purpose, any statements contained in this press release that relate to prospective events or developments are deemed to be forward-looking statements. Words such as "believes," "anticipates," "plans," "expects," "will" and similar expressions are intended to identify forward-looking statements. Our statements of our objectives are also forwar
'/>"/>

SOURCE PLC Systems Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Life Recovery Systems Receives European CE Mark Approval for Its ThermoSuit(R) System
2. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
3. Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007
4. BD and PEPFAR Collaborate to Strengthen Laboratory Systems in Fight Against HIV/AIDS and TB
5. Imaging Diagnostic Systems CTLM Technology Presented at Congress of World Society for Breast Health
6. Imaging Diagnostic Systems Updates PMA Filing Status for the New CT Laser Breast Imaging System
7. PLC Systems Achieves Successful Early Conclusion of RenalGuard(TM) Pilot Safety Trial
8. PLC Medical Systems Names Lead Investigators for Pivotal Trial to Evaluate RenalGuard System(TM) and RenalGuard Therapy(TM)
9. Pharmatech Teams up With Systems Medicine LLC and the Sarcoma Foundation of America for a Phase II Myxoid Liposarcoma Trial
10. PLC Systems Reports Fourth Quarter 2007 Results
11. PLC Systems Receives FDA Approval to Commence Pivotal Study Of RenalGuard(TM) In the U.S.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... Fujirebio Diagnostics Inc., a Malvern-based diagnostics ... Year by the Eastern Technology Council at a ... Philadelphia on Thursday, December 3, 2009. ... region,s largest technology and life sciences trade association. ... and Life Sciences Community, the awards are a ...
(Date:12/14/2009)... Pharmaceuticals, Inc. (Nasdaq: ALXA ) today announced that ... Staccato® loxapine (AZ-004) to the US Food and Drug ... being developed for the rapid treatment of agitation in ... for Staccato loxapine was filed with the ... predictable and consistent safety and efficacy profile in treating ...
(Date:12/14/2009)... 14 Zargis Medical Corp., a majority-owned ... and a spin-off from Siemens Corporate Research (NYSE: ... has begun selling its award-winning Zargis Cardioscan(TM) system ... and its accompanying Bluetooth®-enabled electronic stethoscope were jointly ... "2009 Innovation of the Year." Cardioscan is ...
Breaking Medicine Technology:Fujirebio Diagnostics Named Life Sciences Company of the Year 2Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA 2Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA 3Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA 4Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA 5Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA 6Zargis Cardioscan 'The Intelligent Stethoscope' Now Available on Amazon.com 2New Interventional Pain Management Guidelines Released by the American Society of Interventional Pain Physicians 52999 1New Interventional Pain Management Guidelines Released by the American Society of Interventional Pain Physicians 52999 2New Interventional Pain Management Guidelines Released by the American Society of Interventional Pain Physicians 52999 3Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 1Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 2Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 3Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 4Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 5Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 6Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 7Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 8Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 9Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 10Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 11Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 12Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 13Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 14Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 15Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 16Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 17Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 18Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 19Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 20Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 21Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 22Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 23Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 24Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 25Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 26Zix Corporation Reports Another Record High Revenue Quarter as Company Announces Second Quarter 2009 Financial Results 52991 1Zix Corporation Reports Another Record High Revenue Quarter as Company Announces Second Quarter 2009 Financial Results 52991 2Zix Corporation Reports Another Record High Revenue Quarter as Company Announces Second Quarter 2009 Financial Results 52991 3Zix Corporation Reports Another Record High Revenue Quarter as Company Announces Second Quarter 2009 Financial Results 52991 4Zix Corporation Reports Another Record High Revenue Quarter as Company Announces Second Quarter 2009 Financial Results 52991 5Zix Corporation Reports Another Record High Revenue Quarter as Company Announces Second Quarter 2009 Financial Results 52991 6Zix Corporation Reports Another Record High Revenue Quarter as Company Announces Second Quarter 2009 Financial Results 52991 7Zix Corporation Reports Another Record High Revenue Quarter as Company Announces Second Quarter 2009 Financial Results 52991 8Zix Corporation Reports Another Record High Revenue Quarter as Company Announces Second Quarter 2009 Financial Results 52991 9Zix Corporation Reports Another Record High Revenue Quarter as Company Announces Second Quarter 2009 Financial Results 52991 10Zix Corporation Reports Another Record High Revenue Quarter as Company Announces Second Quarter 2009 Financial Results 52991 11Zix Corporation Reports Another Record High Revenue Quarter as Company Announces Second Quarter 2009 Financial Results 52991 12Zix Corporation Reports Another Record High Revenue Quarter as Company Announces Second Quarter 2009 Financial Results 52991 13Zix Corporation Reports Another Record High Revenue Quarter as Company Announces Second Quarter 2009 Financial Results 52991 14Zix Corporation Reports Another Record High Revenue Quarter as Company Announces Second Quarter 2009 Financial Results 52991 15Zix Corporation Reports Another Record High Revenue Quarter as Company Announces Second Quarter 2009 Financial Results 52991 16Zix Corporation Reports Another Record High Revenue Quarter as Company Announces Second Quarter 2009 Financial Results 52991 17Zix Corporation Reports Another Record High Revenue Quarter as Company Announces Second Quarter 2009 Financial Results 52991 18Zix Corporation Reports Another Record High Revenue Quarter as Company Announces Second Quarter 2009 Financial Results 52991 19
... 27 Immtech Pharmaceuticals,Inc. (Immtech) (Amex: IMM ... Drug,Administration of the People,s Republic of China (SFDA) ... a Phase III clinical,trial with pafuramidine, the Company,s ... (PCP). Pafuramidine is among the first,drugs to be ...
... Sept. 26 Threshold,Pharmaceuticals, Inc. (Nasdaq: THLD ... trial of glufosfamide plus gemcitabine were presented at ... Spain. In the Phase 2 clinical trial ... of advanced pancreatic cancer, six-month and,one-year survival were ...
Other Medicine Technology:Chinese SFDA Grants Immtech Fast Track Status 2Chinese SFDA Grants Immtech Fast Track Status 3Positive Glufosfamide Results From a Phase 2 Clinical Trial Presented at European Cancer Conference (ECCO) 2Positive Glufosfamide Results From a Phase 2 Clinical Trial Presented at European Cancer Conference (ECCO) 3Positive Glufosfamide Results From a Phase 2 Clinical Trial Presented at European Cancer Conference (ECCO) 4
(Date:12/14/2009)... Physician Staff , ... La Jolla, Calif. (Vocus) -- ... Sedwitz, MD, as the new chief of staff of the 372-bed ... physician team on Jan. 1, 2010. , , , , ,During ... to Scripps La Jolla’s administrative staff and its board of directors. ...
(Date:12/14/2009)... of Steve Pasierb, President ,, NEW YORK, ... Michigan,s Monitoring the Future study (MTF) -- the largest ... 10th and 12th graders -- underscores that teens, intentional ... to be a cause for concern, with an alarming ... friends and relatives. ,, Teen Abuse ...
(Date:12/14/2009)... -- The Hemophilia Federation of America (HFA) expresses ... the Teamsters Local 929 and the American Red ... system depends on skilled workers to provide clean, ... into products such as clotting factor for use ... ,, The Division of Blood Services at the ...
(Date:12/14/2009)... had been treated, hadn,t spread, study finds , , MONDAY, ... the risk of death in male colon cancer survivors, ... 1986, included 668 men who,d been treated for stage ... had not spread (nonmetastatic cancer). Every two years, the ... new cancer and disease diagnoses, as well as their ...
(Date:12/14/2009)... protection, study finds, , , MONDAY, Dec. 14 (HealthDay News) ... their morning without a cup or two of java: ... developing type 2 diabetes. , That,s the conclusion ... coffee you drink, the lower your risk of diabetes. ... percent reduction in the risk of diabetes, the researchers ...
Breaking Medicine News(10 mins):Health News:New Chief of Staff Takes Over at Scripps Memorial Hospital La Jolla 2Health News:New Chief of Staff Takes Over at Scripps Memorial Hospital La Jolla 3Health News:Partnership for a Drug-Free America(R) Responds to 2009 Monitoring the Future Study Results 2Health News:Partnership for a Drug-Free America(R) Responds to 2009 Monitoring the Future Study Results 3Health News:HFA Voices Blood Safety Concerns 2Health News:Physical Activity May Prolong Survival After Colon Cancer 2Health News:Coffee, Tea Might Stave Off Diabetes 2Health News:Coffee, Tea Might Stave Off Diabetes 3
... : , , , ... to interact with care providers online are leading causes of patient dissatisfaction ... approach in choosing providers that can make their visits as efficient as possible ... $31 billion of direct adoption incentives are available through American Recovery ...
... Travelers are warned of side effect that could hamper ... The widely used cancer drug capecitabine can cause people ... when they,re trying to enter the United States, an ... in medical oncology at the National Cancer Centre in ...
... in Kandahar, Afghanistan could help surgeons prepare for civilian ... served two tours at the hospital. Dr. Vivian ... at the Schulich School of Medicine & Dentistry at ... at the London Health Sciences Centre. He spent two ...
... Technology, a leading provider of revenue cycle solutions ... announced the firm,s selection as one of the ... one of the top 100 companies playing a ... http://www.newscom.com/cgi-bin/prnh/20090527/LA23009LOGO ) , (Logo: http://www.newscom.com/cgi-bin/prnh/20090325/LA89162LOGO )"Red ...
... Johnson recognized by business leaders for vision, determination and ... Search America , a part of ... health care, today announced that its president, Daniel Johnson, ... & Young Entrepreneur of the Year(R) Award in Minnesota ...
... to develop new and more effective therapies to fight ... Team" of scientists and clinicians that is co-led by ... Department of Energy,s Lawrence Berkeley National Laboratory. , The ... Entertainment Industry Foundation charitable organization aimed at moving cancer ...
Other Medicine News:Health News:Greenway Medical Technologies' PrimePatient Solution Transforms Physician/Patient Relationship Through Enhanced Communication Channels and Improved Workflows 2Health News:Greenway Medical Technologies' PrimePatient Solution Transforms Physician/Patient Relationship Through Enhanced Communication Channels and Improved Workflows 3Health News:Greenway Medical Technologies' PrimePatient Solution Transforms Physician/Patient Relationship Through Enhanced Communication Channels and Improved Workflows 4Health News:Fingerprints May Vanish With Cancer Drug 2Health News:Sharing surgical lessons from the Canadian field hospital in Afghanistan 2Health News:Recondo Technology Wins Red Herring 100 North America Award 2Health News:SearchAmerica(R) President Named as a Finalist for the Ernst & Young Entrepreneur of the Year(R) Award 2Health News:SearchAmerica(R) President Named as a Finalist for the Ernst & Young Entrepreneur of the Year(R) Award 3Health News:Berkeley Lab scientist co-leads breast cancer 'dream team' 2Health News:Berkeley Lab scientist co-leads breast cancer 'dream team' 3
Turnstile casting stand for easy and safe casting. The compact system sets up quickly and stores conveniently, and the non-stick coating prevents fiberglass or plaster from adhering to surface....
CEMEX Fast Set is a solution for multiple indications and preferences. It is a self-contained delivery system in a convenient 70gm size....
... Techno-Aide provides the highest level ... highest quality lead protective eyewear. ... + tolerance allowed. Mfg supervised by ... All lens meet or exceed standards ...
This flexiable metal clip-on easily attaches to most frames and allows for excellent radiation protection. Not available with side shields or in prescription....
Medicine Products: